In the case of SIRT6, low SIRT6 expression was associated with poor overall survival in the hormone-receptor positive subtype, however, SIRT6 was reported to be up-regulated in breast cancer tissues but the changes were statistically insignificant [45]. This evidence concerns the gene NR4A1 and breast cancer.